Zai Lab (ZLAB) News Today

Russell Investments Group Ltd. increased its holdings in shares of Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 51.1% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 293,783 shares of the company's stock after acquirin

Zai Lab (NASDAQ:ZLAB) Trading 6.6% Higher

M&G Plc bought a new stake in Zai Lab Limited (NASDAQ:ZLAB - Free Report) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 454,128 shares of the company's stock, valued at approximately $7,26

Zai Lab (NASDAQ:ZLAB) Sees Strong Trading Volume

JPMorgan Chase & Co. dropped their price objective on shares of Zai Lab from $43.00 to $38.00 and set an "overweight" rating for the company in a report on Friday.

Zai Lab Limited (NASDAQ:ZLAB - Get Free Report) CEO Ying Du sold 7,013 shares of the firm's stock in a transaction that occurred on Monday, July 1st. The shares were sold at an average price of $17.48, for a total transaction of $122,587.24. Following the completion of the sale, the chief executive officer now owns 1,081,910 shares of the company's stock, valued at $18,911,786.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Zai Lab Limited (NASDAQ:ZLAB - Get Free Report) CFO Yajing Chen sold 2,154 shares of Zai Lab stock in a transaction on Wednesday, June 26th. The shares were sold at an average price of $17.90, for a total transaction of $38,556.60. Following the completion of the sale, the chief financial officer now directly owns 13,714 shares of the company's stock, valued at approximately $245,480.60. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Zai Lab (NASDAQ:ZLAB) Shares Gap Down to $18.75

Cantor Fitzgerald restated an "overweight" rating on shares of Zai Lab in a research report on Tuesday.

Wellington Management Group LLP grew its stake in shares of Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 177.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 5,336,457 shares of t

Bellevue Group AG purchased a new stake in shares of Zai Lab Limited (NASDAQ:ZLAB - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 135,000 shares of the company's sto

Hsbc Holdings PLC decreased its position in Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 82.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 57,348 shares of the company's stock after selling 270,433 shares during

Brilliance Asset Management Ltd. boosted its stake in Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 177.5% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 435,926 shares of the company's stock after buying

Zai Lab (NASDAQ:ZLAB) Stock Price Up 4.2%

Zai Lab (NASDAQ:ZLAB) Stock Price Down 2.1%

Zai Lab (NASDAQ:ZLAB) Shares Gap Up to $18.00

Allianz Asset Management GmbH lifted its position in Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 26.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 679,524 shares of the company's stock after

Zai Lab (NASDAQ:ZLAB) Shares Gap Down to $20.16

Zai Lab (NASDAQ:ZLAB) Stock Price Down 4.4%

Zai Lab (NASDAQ:ZLAB) Shares Gap Up to $19.40

Zai Lab Limited (NASDAQ:ZLAB - Get Free Report) insider Frazor Titus Edmondson III sold 10,000 shares of Zai Lab stock in a transaction that occurred on Tuesday, May 14th. The shares were sold at an average price of $21.33, for a total value of $213,300.00. Following the completion of the transaction, the insider now owns 16,408 shares of the company's stock, valued at $349,982.64. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Zai Lab (NASDAQ:ZLAB) Shares Gap Down to $20.85

Zai Lab (NASDAQ:ZLAB) Shares Up 9.7%

Segantii Capital Management Ltd trimmed its holdings in Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 5.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,687,569 shares of the company's stock a

Zai Lab (NASDAQ:ZLAB - Get Free Report) issued its quarterly earnings data on Wednesday. The company reported ($0.55) earnings per share for the quarter, topping analysts' consensus estimates of ($0.93) by $0.38. The firm had revenue of $87.15 million for the quarter, compared to analyst estimates of $77.07 million. Zai Lab had a negative return on equity of 37.07% and a negative net margin of 125.46%. During the same period last year, the company earned ($0.51) EPS.